Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

OBJECTIVE: Sarcomeric gene mutation carriers without overt left ventricular hypertrophy (G+/LVH−) can harbour subclinical changes in cardiovascular structure and function that precede the development of hypertrophic cardiomyopathy (HCM). We sought to investigate if circulating biomarkers of cardiova...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Heart
Main Authors: Ho, Jennifer E, Shi, Ling, Day, Sharlene M, Colan, Steven D, Russell, Mark W, Towbin, Jeffrey A, Sherrid, Mark V, Canter, Charles E, Jefferies, John Lynn, Murphy, Anne, Taylor, Matthew, Mestroni, Luisa, Cirino, Allison L, Sleeper, Lynn A, Jarolim, Peter, Lopez, Begoña, Gonzalez, Arantxa, Diez, Javier, Orav, E John, Ho, Carolyn Y
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Heart Failure and Cardiomyopathies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5687543/
https://ncbi.nlm.nih.gov/pubmed/29177058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2017-000615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados